COMBI.ST Current Ratio

The Current Ratio of Combigene AB (COMBI.ST) is 17.44.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

COMBI.ST Current Ratio - Historical Value

Date	Value
2024-12-31	17.44
2023-12-31	24.84
2022-12-31	22.83
2021-12-31	18.21
2020-12-31	6.94
2019-12-31	0.80
2018-12-31	2.28
2017-12-31	4.25
2016-12-31	4.53

COMBI.ST Current Ratio - Peers Comparison

Ticker	Name	Value
ALPRE.PA	Predilife SA	3.22
EVG.L	Evgen Pharma PLC	7.36
PROB.ST	Probi AB	6.94
VITR.ST	Vitrolife AB	3.34
XINT.ST	Xintela AB	0.78
ABNX.PA	Abionyx Pharma SA	1.58
BONEX.ST	Bonesupport Holding AB	4.32
GUARD.ST	Guard Therapeutics International AB (publ)	3.14
IMMU.ST	Mendus AB (publ)	4.29
BIOA B.ST	BioArctic AB	5.75
GEN.WA	Genomed SA	6.28
GKTX.PA	GenKyoTex SA	1.29
IVACC.ST	Intervacc AB	2.03
LIDDS.ST	Lidds AB	4.86
VAL.L	ValiRx PLC	2.64
AEGIR.ST	Aegirbio AB	1.64
ALNEV.PA	Neovacs SA	1.03
ALPAT.PA	Plant Advanced Technologies PAT SA	2.11
ISR.ST	ISR Immune System Regulation Holding AB (publ)	0.03
TOL.ST	Toleranzia AB	2.42
ACTI.ST	Active Biotech AB publ	4.40
ALLR.ST	Allarity Therapeutics A/S	0.40
GV.PA	Genomic Vision SA	0.91
MTPH.L	Midatech Pharma PLC	6.39
SCS.WA	Stem Cells Spin SA	0.16
SENZA.ST	SenzaGen AB	2.66
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	1.04
ALNOX.PA	Noxxon Pharma NV	1.84
BIOG B.ST	Biogaia AB	7.81
HNSA.ST	Hansa Biopharma AB	2.29
IDOGEN.ST	Idogen AB	1.67
IKM.MC	1nkemia IUCT Group SA	0.08
SPRINT.ST	Sprint Bioscience AB	1.14
XBRANE.ST	Xbrane Biopharma AB	1.13
ALZ.ST	Alzinova AB	2.16
PROMO.ST	Promore Pharma AB	3.33
RDG.WA	Read Gene SA	10.30